The U.S. Female Infertility Diagnosis & Treatment Market to 2025 - Contains End-user Insights for Hospitals & Clinics, Homecare, and Pathology & Diagnostic Centers

News provided by

Mar 18, 2020, 11:15 ET

DUBLIN, March 18, 2020 /PRNewswire/ -- The "US Female Infertility Diagnosis And Treatment Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The US female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.8% during the forecast period.

The US Female infertility diagnosis and treatment diagnosis and treatment market is growing significantly due to various factors such as increasing infertility rate among females, unhealthy lifestyle and development of new technologies in IVF treatment. Apart from these factors, the rising trend of surrogacy in the country is also driving the growth of the market. According to the American Pregnancy Association in 2017, infertility affects around 6 million American couples, which corresponds to around 10% of American females of childbearing age. In addition, around 25% of infertile couples have more than one cause of infertility. The growing infertility rate creates the demand for infertility diagnosis and treatment, which in turn, drives the market growth.

The US Female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.

Some of the major players operating in the US female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in The US market.

The report covers:

A comprehensive research methodology of the US female infertility diagnosis and treatment market.
A detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the US female infertility diagnosis and treatment market.
Insights about market determinants which are stimulating the US female infertility diagnosis and treatment market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Key Topics Covered

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight& Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. The US Female Infertility Diagnosis and Treatment Market by Diagnosis
5.1.1. Ovulation Testing
5.1.2. Hysterosalpingography (HSG)
5.1.3. Hysteroscopy
5.1.4. Imaging Testing
5.1.5. Ovarian Reserve Testing
5.1.6. Hormonal Level Testing
5.1.7. Genetic Testing
5.1.8. Others (Laparoscopy)
5.2. The US Female Infertility Diagnosis and Treatment Market by Treatment
5.2.1. Drugs
5.2.2. Surgery
5.2.3. Intrauterine Insemination (IUI)
5.2.4. Assisted Reproductive Technology (ART)
5.3. The US Female Infertility Diagnosis and Treatment Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Homecare
5.3.3. Pathology and Diagnostic Centers

6. Company Profiles
6.1. Church & Dwight Co.
6.2. Cook Group Inc.
6.3. Eli Lilly Co.
6.4. Fairhaven Health, LLC
6.5. FUJIFILM Irvine Scientific, Inc.
6.6. Millendo Therapeutics, Inc.
6.7. Pfizer Inc.
6.8. Princeton BioMeditech Corp
6.9. Bayer AG
6.10. Church & Dwight Co. Inc.
6.11. Vitrolife
6.12. Cook Medical, Inc.
6.13. Eli Lilly & Co.

For more information about this report visit https://www.researchandmarkets.com/r/ujkft2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets